In the first half of 2020, ON Partners consultants completed several high-level executive life sciences and healthcare placements for a wide range of organizations including Gilead, IGM Biosciences, Sangamo Therapeutics, Thermo Fisher Scientific and more.

In addition to a busy first half of 2020 in this high demand sector, ON Partners was also ranked in the Hunt Scanlon Top 50 Healthcare and Life Sciences Search Firm list for 2019.  This ‘Top 50’ ranking of specialist search firms dedicated to these two powerful sectors is presented by Hunt Scanlon for the first time ever.

Contact ON

First Half 2020 Executive Placements

We believe a better executive search experience matters, and that experience starts with expert, tenured specialists.  We’ve been serving the healthcare and life sciences sector since our inception in 2006. Our expert consultants bring substantial recruiting and operating experience with a solid understanding of what creates successful, effective leaders in this highly regulated and demanding scientific space.

At ON Partners, we’ve been closely tracking shifts in leadership demand as it relates to life sciences, telemedicine and healthcare during the pandemic, and our team of consultants have made a significant number of recent placements in the space, including:

Allscripts – SVP, Technology

ON consultants: Matt Mooney and Danny Bolger

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results.

BlackThorn Therapeutics – VP, Clinical Development

ON consultant: Steve Cornacchia

BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders.

CATO-SMS Research (CATO) – VP, Clinical Trial Operations and VP, IT 

ON consultant: Lenny Vairo

CATO-SMS Research (CATO), funded by Water Street Healthcare Partners, is a global provider of solutions that support life science organizations with advancing drug development.

Gilead – SVP, Biology

ON consultant: Suzanne Zebedee, Ph.D.

Gilead Sciences, Inc. (Nasdaq: GILD) is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. 

IGM Biosciences – VP, Antibody Discovery

ON consultant: Suzanne Zebedee, Ph.D.

Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. 

Merit Medical Systems – Board of Directors

ON consultant: Steve Cornacchia

Founded in 1987, Merit Medical Systems, Inc. (NASDAQ: MMSI) is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. 

Nature’s Toolbox (NTx) – Chief Commercial Officer

ON consultant: Suzanne Zebedee, Ph.D.

Nature’s Toolbox, Inc. (NTx) is an early stage biomanufacturing and bioinformatics company based in Santa Fe, NM. The company has developed a proprietary host-independent biological manufacturing and development platform used for pharmaceutical drug discovery and manufacturing of biologicals to counter disease.

Optical Biosystems – CEO

ON consultant: Suzanne Zebedee, Ph.D.

Optical Biosystems is a spatial genomics company enabling the next generation of biological research.

Ortho Clinical Diagnostics – VP, Global Information Services

ON consultants: Steve Cornacchia and Marc Gasperino

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. 

Sangamo Therapeutics – VP, Genome Engineering

ON consultant: Steve Cornacchia

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. 

Thermo Fisher Scientific – VP, IT Digital Engineering and VP, IT Customer Channels Group

ON consultants: Steve Cornacchia and Joe Olson

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion through industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. 

Leadership Demand in Life Sciences and Healthcare

There’s no question the coronavirus has altered the global business landscape, and with it, the demand on executive leadership.  Based on conversations with executive leaders across multiple industry sectors, ON Partners’ consultants have analyzed their input and compiled predictions on expected changes in leadership demand post-pandemic.

In the ON Viewpoint series, executive recruiting specialists predict how COVID-19 will transform the demand for leadership in business sectors and functions including telemedicine, life sciences and healthcare.

Learn more about our life sciences and healthcare executive search services here.

ABOUT ON PARTNERS

ON Partners propels an organization’s mission by building C-level and board leadership teams. Founded in 2006 by like-minded consultants as a values-driven alternative to the multi-service global firms they were leaving behind, ON delivers a better executive search experience. Named by Forbes as one of America’s Best Executive Recruiting Firms and to the Inc. 500/5000 Lists six times, the firm is consistently ranked among the top 20 retained executive search firms in the U.S.

Follow our work, updates and recent success on Twitter and LinkedIn.

Find our related successful placements of leading executives here.